Short answer
SANUWAVE Health, Inc. (SNWV) filed an 8-K current report with the SEC on June 16, 2026 reporting Item 7.01 (Regulation FD Disclosure), Item EX-99.1 (Exhibit EX-99.1). Reg FD disclosure section contains only incorporation-by-reference and liability disclaimers.
SANUWAVE Health, Inc. 8-K event analysis
AI summary of each reported item and its exhibits
Item 7.01 · Regulation FD Disclosure
- Reg FD disclosure section contains only incorporation-by-reference and liability disclaimers
- No substantive company update or investor-actionable information disclosed in the provided text
Item EX-99.1 · Exhibit EX-99.1
- Q2 2026 revenue guidance reduced to $8.5–$9.5 million, signaling near-term pressure on capital-equipment sales
- CMS reimbursement clawbacks are forcing wound-care practice closures and weakening customer purchasing capacity
- Used Ultramist systems entering the market are materially cannibalizing new-system sales
- Record Q2 applicator shipment volumes support recurring consumables demand despite weaker system placements
- Secondary-market growth creates an opportunity to train new users but raises regulatory, quality, and liability risks
Generated from the filing text and exhibits; verify against the original. What 8-K item codes mean
Other SANUWAVE Health, Inc. 8-K filings
Get the next SNWV 8-K as it lands
Follow SNWV for push alerts, or ask the research agent what this filing means.